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Abstract
Axillary lymph node metastasis (ALNM) from cancer except breast cancer is rare. Whole body 18F-Fluorodeoxyglucose positron 
emission tomography/computed tomography (PET/CT) that simultaneously offers anatomic and metabolic information is widely 
used and has become an effective modality in many clinical fields, especially oncology, and also may detect an unexpected 
metastasis. We report two cases of ALMN of nasopharyngeal and cervical cancer that was detected on whole body PET/CT.
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Background
18F-Fluorodeoxyglucose positron emission tomography/com-
puted tomography (PET/CT) assesses tumor metabolic activity. It 
is a useful tool in a variety of cancers [1]. PET/CT also may detect 
incidental metastasis due to whole body image [2, 3]. Axillary lymph 
node metastasis (ALNM) from cancer, except breast cancer is rare. 
Only a few cases of ALNM from nasopharyngeal and cervical cancer 
have been described. This case report describes cases of unsus-
pected ALNM from nasopharyngeal cancer (NPC) and cervical can-
cer (CC) confirmed with PET/CT imaging and subsequent biopsy.
Case report
Case 1
A 64-year-old woman had a past medical history of combined 
chemo-radiotherapy for squamous cell carcinoma in the cervix 
with stage IVb (T4N1M1, ovarian metastasis) 6 years previously, 
with chemotherapy due to recurrence in the para-aortic lymph 
nodes one year later. She had been free of disease for 5 years with 
annual follow-up study using enhanced abdominal CT scan. PET/CT 
was performed to detect tumor recurrence or metastasis of known 
cervical cancer and other hidden malignancy. PET/CT revealed 
a nodular lesion with FDG uptake, with a maximum standardized 
uptake value (SUVmax) of 3.97 in the left axilla (Figure 1). Biopsy 
was performed under ultrasonographic guidance. Metastatic le-
sion from CC was confirmed by microscopic examination of the 
specimen.
Case 2
A 64-year-old woman had a past medical history of combined 
chemo-radiotherapy for squamous cell carcinoma in the naso-
pharyngeal wall with stage IVA (T4N1M0) 12 years previously and 
radical neck dissection due to recurrence in the cervical lymph 
nodes two years later. She had been free of disease for 11 years with 
annual follow-up study of physical examination of head and neck ar-
eas and enhanced neck CT scan. PET/CT was performed to detect 
tumor recurrence or metastasis of known nasopharyngeal cancer 
and other hidden malignancy. PET/CT showed nodular lesion with 
FDG uptake, with SUVmax of 8.07 in the right axilla (Figure 2). Biopsy 
Figure 1. Whole body 18FDG PET/CT in MIP, coronal and transaxial 
views demonstrated an isolated hypermetabolic focus in left enlarged 
axillary lymph node (SUVmax 3.97, red arrow)
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was performed under ultrasonographic guidance. Metastatic lesion 
from NPC was confirmed by microscopic examination.
Discussion
CC is the second most common cancer among women globally 
and is a leading cause of cancer mortality [4]. In a previous study, 
30 women with locally advanced tumors who had undergone 
PET/CT during the surveillance period were evaluated. PET/CT 
facilitated the detection of local and distant metastasis with a sen-
sitivity of 93–96% and a specificity of 93–95% [5]. The route of 
LNM from the abdominal para-aortic lymph nodes of CC is first to 
the cisterna chyli and then to the thoracic duct. The thoracic duct 
empties into the venous system at the junction of the left subclavian 
and internal jugular veins. Before emptying into the venous system, 
the thoracic duct arches above the clavicle and incorporates the 
scalene lymph nodes into the efferent lymph flow [6]. But ALN 
falls outside of this lymphatic flow. ALN normally receives lymphatic 
drainage from the upper limbs and chest wall. One hypothesized 
route of ALNM from bronchogenic carcinoma is the systemic vas-
cular route, considering that there are no channels of lymphatic 
communication from the lungs to the ALN [7, 8]. One of the present 
cases conformed to this hypothesis.
NPC often develops regional and distant metastases [9]. Su-
praclavicular nodal metastases represent the most advanced extent 
of regional spread [10] and are associated with a greater than 50% 
risk of distant metastases after curative-intent local-regional therapy. 
The skeletal system, the thorax and the liver are the most frequent 
sites of distant metastatic spread in NPC [11]. The orderly spread 
of nodal metastases in the cephalad-caudal direction in NPC [12] 
suggests the possibility that the superior mediastinal and axillary 
nodes could be the next station for lymphatic spread after supra-
clavicular nodal metastases [13]. Recurrence and metastasis are 
commonly seen after the initial treatment of advanced NPC, which 
can lead to the failure of first-cycle radiotherapy in up to 25% of 
cases. Moreover, distant metastasis is the primary reason for failure, 
accounting for 53.6–63.1% of recurrence [14]. One of the present 
cases featured a high stage and recurrence in one year.
PET/CT is a useful method for detection of local recurrence and 
distant metastasis compared with conventional anatomical imaging 
[15]. The potential role of PET/CT in the management of NPC and 
CC might be its ability to image the entire body for additional site of 
metastatic disease. In these cases, enhanced neck and abdominal 
CT scans for follow-up of NPC and CC did not detect ALMN.
Conclusions
To our knowledge, this is the first report of a NPC and CC devel-
oping an ALNM on F-18 FDG PET/CT. These cases represent rare 
presentation of recurrent NPC and CC, and illustrate the importance 
of a comprehensive physical examination and correlation with 
whole body PET/CT when following high stage patients over time.
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Figure 2. Whole body 18F-FDG PET/CT in MIP, coronal and transaxial 
views demonstrated an isolated hypermetabolic focus in right enlarged 
axillary lymph node (SUVmax 8.07, red arrow)
